Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

quadraspec.com

Founded Year

2004

Stage

Series C | Alive

Total Raised

$10.3M

Last Raised

$2.5M | 14 yrs ago

About QuadraSpec

Quadraspec is changing the face of diagnostic medicine. Quadraspec's patented SDI label-free detection technology aims to permit the rapid analysis of up to 100 unique tests on up to 1,000 unique patients per hour. Quadraspec's , multiplex-capable diagnostics platform aims to allow high throughput, label-free, highly sensitive bioassays, and diagnostics.

QuadraSpec Headquarters Location

3000 Kent Avenue

West Lafayette, Indiana, 47906,

United States

765-775-1026

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest QuadraSpec News

Quadraspec Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 30, 2016

Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 20:58 EST 29 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Quadraspec, Inc. since January 2007. Key Findings Provides intelligence on Quadraspec, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Quadraspec, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Quadraspec, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Quadraspec, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

  • When was QuadraSpec founded?

    QuadraSpec was founded in 2004.

  • Where is QuadraSpec's headquarters?

    QuadraSpec's headquarters is located at 3000 Kent Avenue, West Lafayette.

  • What is QuadraSpec's latest funding round?

    QuadraSpec's latest funding round is Series C.

  • How much did QuadraSpec raise?

    QuadraSpec raised a total of $10.3M.

  • Who are the investors of QuadraSpec?

    Investors of QuadraSpec include Spring Mill Venture Partners, EDF Ventures, 1st Source Capital Corporation, CHV Capital and Village Ventures.

  • Who are QuadraSpec's competitors?

    Competitors of QuadraSpec include VIDA Diagnostics, Ikonisys, Binx Health, Decipher Biosciences, Foundation Medicine and 16 more.

You May Also Like

M
Modules for Novel Diagnostics

MND Diagnostics is a healthcare company focused on disease diagnosis. The medical device company has developed a diagnostic detection platform which aims to be rapid, low-priced and portable.

N
NIR Diagnostics

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.

N
Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

K
Knoesis

Knoesis seeks to develop bio-analytical hardware and reagents enabling cost-effective clinical diagnostics. The vision of the company is to allow everyone affordable access to rapid and specific diagnostic healthcare knowledge. Knoesis' first application is an immunosensor for the detection of latent tuberculosis infection.

N
NeoDiagnostix

NeoDiagnostix develops molecular diagnostic and prognostic tests for the treatment of cancer. The company's test results eliminate the ambiguity experienced in millions of samples analyzed by traditional cytomorphology-based cell analyses. The company is committed to providing physicians with information that will improve patient care and treatment.

T
Tympany

Tympany is developing automated, hearing, diagnostic technology. Tympany aims to improve early detection of hearing loss, increase access to diagnostics, and facilitate the ease and convenience of personalized treatment. The company is located in The Woodlands, Texas, with regional offices throughout the U.S

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.